Hans Hoffmann

11.5k citations
154 papers · 5.6k · 1 hit paper · h-index 41

Impact in

    • Lung Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
    • Medical Imaging and Pathology Studies
    • Pleural and Pulmonary Diseases
  • Oncology top 2%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Lung Cancer Diagnosis and Treatment 44
    • Lung Cancer Treatments and Mutations 28
    • Pleural and Pulmonary Diseases 11
    • Occupational and environmental lung diseases 8
    • Lung Cancer Research Studies 12
    • Cancer Immunotherapy and Biomarkers 7

Hans Hoffmann

139 papers receiving 5.5k citations

Hans Hoffmann's Hit Papers

The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival 2012 · 559 citations
5590+4+9Years since publication100200300400500

Peers

Hans Hoffmann
Comparison fields: 5 of 118
  • Pulmonary and Respiratory Medicine 2.7k
  • Oncology 1.3k
  • Hepatology 353
  • Cancer Research 343
  • Radiology, Nuclear Medicine and Imaging 414
Replace Michael Lanuti with:
Michael Lanuti United States
Marco Alloisio Italy
Haruhiko Kondo Japan
Ashley E. Winkler United States
Daniel J. Boffa United States
Clifton F. Mountain United States
Norihiko Ikeda Japan
Ryosuke Tsuchiya Japan
Wallace Akerley United States
Ramón Rami–Porta Spain
Hans Hoffmann relative to Michael Lanuti United States Michael Lanuti's profile →
Citations per field
00.5×1.5×
Michael Lanuti · 1×
Citations per year

Countries citing papers authored by Hans Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Hans Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Hoffmann more than expected).

Fields of papers citing papers by Hans Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Hoffmann. The network helps show where Hans Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Hans Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hans Hoffmann Line = papers co-authored together Hans Hoffmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
Hit paper breakdown →
2012559
2 2007435
3 2012257
4 2003202
5 2002187
6 2008155
7 2018137
8 2006125
9 2007113
10 2007108
11 201299
12 201099
13 201298
14 201293
15 201191
16 200691
17 200984
18 201180
19
Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
201577
20 201076

About Hans Hoffmann

Hans Hoffmann is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 154 papers that have together received 5.6k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (44 papers), Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (12 papers), Pleural and Pulmonary Diseases (11 papers), Occupational and environmental lung diseases (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.7k citations), Oncology (1.3k citations), Hepatology (353 citations), Cancer Research (343 citations) and Radiology, Nuclear Medicine and Imaging (414 citations). Hans Hoffmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hendrik Dienemann, Joachim Pfannschmidt, Thomas Muley, Arne Warth, Philipp A. Schnabel, Felix Herth, Michael Meister, Peter Schirmacher, Michael Thomas and Wilko Weichert. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, The Annals of Thoracic Surgery, BMC Cancer and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact